Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 10.5B | 9.5B | 10.5B | 10.1B |
Cost of revenue | 2.9B | 2.6B | 4.1B | 2.5B |
Gross profit | 7.6B | 7.0B | 6.4B | 7.6B |
Operating expense | ||||
Research & development | 2.2B | 1.9B | 2.7B | 2.0B |
Selling general and admin | 1.5B | 1.3B | 1.8B | 1.7B |
Other operating expenses | — | — | — | — |
Operating income | 3.2B | 3.0B | 434.6M | 1.9B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 413.3M | 421.0M | 422.7M | 430.4M |
Other income expense | -1.3B | -28.1M | 137.2M | 7.7M |
Pretax income | 1.5B | 2.5B | 149.1M | 1.4B |
Tax provision | 392.0M | 433.8M | 84.4M | 392.9M |
Net income | 1.1B | 2.1B | 64.8M | 1.0B |
Basic EPS | — | 1.2 | 0.0 | 0.6 |
Diluted EPS | — | 1.2 | 0.0 | 0.6 |
Basic average shares | — | 1.7B | 1.7B | 1.7B |
Diluted average shares | — | 1.7B | 1.7B | 1.7B |
EBITDA | 4.5B | 4.3B | 2.4B | 4.4B |
Net income from continuing op. | 1.1B | 2.1B | 64.8M | 1.0B |
Minority interests | -1.7M | -5.1M | -3.4M | -3.4M |
Preferred stock dividends | — | — | — | — |